{"id":"W4412124270","doi":"10.1093/crocol/otaf031","title":"Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naïve Patients With Early or Late Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"Takeda Foundation","keywords":"Vedolizumab; Ustekinumab; Crohn's disease; Medicine; Disease; Dermatology; Internal medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004815155,0.0002274725,0.0003340619,0.00005560801,0.0001248428,0.00003867672,0.0001905188,0.0001251988,0.000005496197],"category_scores_gemma":[0.0005492711,0.0001496953,0.00005746465,0.0001560965,0.0003593828,0.0000114487,0.0003038598,0.0001450813,0.000001018426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000386822,"about_ca_system_score_gemma":0.000266956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007661264,"about_ca_topic_score_gemma":0.003173527,"domain_scores_codex":[0.9976624,0.000761907,0.0005275659,0.0006533568,0.0001442651,0.0002504931],"domain_scores_gemma":[0.9985499,0.0003574191,0.0002085209,0.0005860305,0.0001707776,0.0001273123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06473343,0.0003644888,0.930624,0.00004603816,0.0001139224,0.0002271526,0.0001639938,0.00001038081,0.00005943397,0.00003298075,0.00007381736,0.003550376],"study_design_scores_gemma":[0.009190043,0.0004558942,0.9893432,0.0002524347,0.00009695932,2.338096e-7,0.0001235601,0.0000161069,0.00007076251,0.000093783,0.0001736264,0.0001834587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99722,0.0001774694,0.000008725157,0.00002435827,0.0001214795,0.001571562,0.000709667,0.00001206719,0.0001546469],"genre_scores_gemma":[0.9992768,0.0001605722,0.00003075191,0.00006461758,0.00004826721,0.00008865966,0.0001689333,0.00001732255,0.0001440639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05871916,"threshold_uncertainty_score":0.6104397,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01162384803834654,"score_gpt":0.2865311887779796,"score_spread":0.274907340739633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}